These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 20641106

  • 1. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.
    Hamada T, Kubo T, Kitaoka H, Hirota T, Hoshikawa E, Hayato K, Shimizu Y, Okawa M, Yamasaki N, Matsumura Y, Yabe T, Takata J, Doi YL.
    Clin Cardiol; 2010 Jul; 33(7):E24-8. PubMed ID: 20641106
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.
    Goto D, Kinugawa S, Hamaguchi S, Sakakibara M, Tsuchihashi-Makaya M, Yokota T, Yamada S, Yokoshiki H, Tsutsui H, JCARE-CARD Investigators.
    J Cardiol; 2013 Jan; 61(1):65-70. PubMed ID: 23078864
    [Abstract] [Full Text] [Related]

  • 3. Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy.
    Aizawa Y, Tanimoto Y, Hirata Y, Fujisawa T, Fukuoka R, Nakajima K, Katsumata Y, Nishiyama T, Kimura T, Yuasa S, Kohno T, Kohsaka S, Murata M, Maekawa Y, Furukawa Y, Takatsuki S, Fukuda K.
    Keio J Med; 2019 Dec 25; 68(4):87-94. PubMed ID: 30606897
    [Abstract] [Full Text] [Related]

  • 4. Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.
    Tanaka H, Tatsumi K, Matsuzoe H, Matsumoto K, Hirata KI.
    Cardiovasc Diabetol; 2020 Jun 13; 19(1):84. PubMed ID: 32534593
    [Abstract] [Full Text] [Related]

  • 5. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.
    Aleksova A, Sabbadini G, Merlo M, Pinamonti B, Barbati G, Zecchin M, Bussani R, Silvestri F, Iorio AM, Stolfo D, Dal Ferro M, Dragos AM, Meringolo G, Pyxaras S, Lo Giudice F, Perkan A, di Lenarda A, Sinagra G.
    J Cardiovasc Med (Hagerstown); 2009 Sep 13; 10(9):699-705. PubMed ID: 19474760
    [Abstract] [Full Text] [Related]

  • 6. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF.
    Circ Heart Fail; 2013 Sep 01; 6(5):913-21. PubMed ID: 23888044
    [Abstract] [Full Text] [Related]

  • 7. Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling.
    Lapu-Bula R, Robert A, De Kock M, D'Hondt AM, Detry JM, Melin JA, Vanoverschelde JL.
    Am J Cardiol; 1998 Sep 15; 82(6):779-85. PubMed ID: 9761090
    [Abstract] [Full Text] [Related]

  • 8. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ, Xu J, Du W, Zhang JX, Zhong M, Zhou YN.
    Int J Cardiovasc Imaging; 2016 Dec 15; 32(12):1725-1733. PubMed ID: 27566192
    [Abstract] [Full Text] [Related]

  • 9. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA, Schinkel AF, de Groot NM, van Domburg RT, Ten Cate FJ, Michels M.
    Clin Cardiol; 2014 Aug 15; 37(8):493-8. PubMed ID: 25044226
    [Abstract] [Full Text] [Related]

  • 10. Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.
    Reant P, Mirabel M, Lloyd G, Peyrou J, Lopez Ayala JM, Dickie S, Bulluck H, Captur G, Rosmini S, Guttmann O, Demetrescu C, Pantazis A, Tome-Esteban M, Moon JC, Lafitte S, McKenna WJ.
    Heart; 2016 May 15; 102(10):741-7. PubMed ID: 26857213
    [Abstract] [Full Text] [Related]

  • 11. The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance.
    Pinamonti B, Merlo M, Nangah R, Korcova R, Di Lenarda A, Barbati G, Sinagra G.
    J Cardiovasc Med (Hagerstown); 2010 Sep 15; 11(9):669-77. PubMed ID: 20216227
    [Abstract] [Full Text] [Related]

  • 12. Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy.
    Kim H, Park JH, Won KB, Yoon HJ, Park HS, Cho YK, Nam CW, Han S, Hur SH, Kim YN, Kim KB.
    Heart; 2016 Aug 01; 102(15):1215-20. PubMed ID: 26969633
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F, Satoh H, Shiraki K, Saitoh T, Urushida T, Katoh H, Takehara Y, Sakahara H, Hayashi H.
    J Card Fail; 2007 Jun 01; 13(5):372-9. PubMed ID: 17602984
    [Abstract] [Full Text] [Related]

  • 14. [Clinical and echocardiographic evaluation of the effects of atrial defibrillation in patients with idiopathic cardiomyopathy].
    Shite J, Yokota Y, Nakatani M, Takeuchi Y, Tsumura Y, Kawai H, Ueno H, Kawashima T, Honda Y.
    J Cardiol; 1992 Jun 01; 22(1):73-82. PubMed ID: 1307580
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S, Rodrigues J, Campelo M, Moura B, Martins E, Macedo F, Silva-Cardoso J, Maciel MJ.
    Int J Cardiovasc Imaging; 2017 May 01; 33(5):605-613. PubMed ID: 28013418
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.
    Eda Y, Nabeta T, Iikura S, Takigami Y, Fujita T, Iida Y, Ikeda Y, Ishii S, Ako J.
    ESC Heart Fail; 2024 Jun 01; 11(3):1463-1471. PubMed ID: 38320776
    [Abstract] [Full Text] [Related]

  • 18. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
    Jang JH, Shin SH, Beak YS, Ko KY, Kwon SW, Park SD, Woo SI, Kim DH, Kwan J.
    Heart Vessels; 2020 Feb 01; 35(2):214-222. PubMed ID: 31482215
    [Abstract] [Full Text] [Related]

  • 19. Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
    Kitaoka H, Kubo T, Hayashi K, Yamasaki N, Matsumura Y, Furuno T, Doi YL.
    Eur Heart J Cardiovasc Imaging; 2013 Jun 01; 14(6):544-9. PubMed ID: 23060455
    [Abstract] [Full Text] [Related]

  • 20. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM, Park JY, Sara JD, Hodge DO, Gersh BJ, Nishimura RA, Asirvatham SJ, McLeod CJ.
    Europace; 2018 Jan 01; 20(1):82-88. PubMed ID: 29315424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.